Elevance Health Inc.
ELV evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for ELV—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$84.37B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Mar 31, 2026.
Run Elevance Health Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Elevance Health Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 1.86 · 1% dilution
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
1 buy · 3 sells (180d)
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1,457
Total value held
$55.53B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 28,690,918 | $8.40B |
| blackrock, inc. | 19,887,111 | $5.82B |
| state street corp | 10,288,696 | $3.01B |
| first eagle investment management, llc | 8,264,582 | $2.42B |
| wellington management group llp | 8,228,537 | $2.41B |
| vanguard portfolio management llc | 6,356,077 | $1.86B |
| geode capital management, llc | 5,192,707 | $1.51B |
| harris associates l p | 5,136,526 | $1.50B |
| bank of new york mellon corp | 2,845,280 | $833.0M |
| bank of america corp /de/ | 2,718,766 | $795.9M |
Showing top 10 of 1,457 institutional holders of Elevance Health Inc.. Open the full 13F history after sign-in.
Short Interest
as of May 10, 2026- % of float
- 2.3%
- Days to cover
- 2.8
- Shares short
- 4,417,945
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
ELV short interestGovernance
Frequently asked questions
Who is the CEO of Elevance Health Inc.?
Ms. Gail Koziara Boudreaux is the chief executive officer of Elevance Health Inc. (ELV).
Where is Elevance Health Inc. headquartered?
Elevance Health Inc. (ELV) is headquartered in Indianapolis, IN, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.